---
title: "UnitedHealth Note 1"
type: "Topics"
locale: "zh-CN"
url: "https://longbridge.com/zh-CN/topics/39596963.md"
description: "UnitedHealth PE range based on UnitedHealth (UNH) history, sector, and current environment, giving you the most practical PE range division (uniformly using forward-looking PE..."
datetime: "2026-03-28T09:11:00.000Z"
locales:
  - [en](https://longbridge.com/en/topics/39596963.md)
  - [zh-CN](https://longbridge.com/zh-CN/topics/39596963.md)
  - [zh-HK](https://longbridge.com/zh-HK/topics/39596963.md)
author: "[小马哥的交易员](https://longbridge.com/zh-CN/profiles/15302149.md)"
---

> 支持的语言: [English](https://longbridge.com/en/topics/39596963.md) | [繁體中文](https://longbridge.com/zh-HK/topics/39596963.md)


# UnitedHealth Note 1

## UnitedHealth PE Range

Based on UnitedHealth's (UNH) history, sector, and current environment, here's the most practical PE range breakdown (using forward-looking dynamic PE, not TTM):

I. Undervalued Range (Safe Buy Zone)

≤16x (Dynamic PE)

• Characteristics: Extreme market pessimism, MCR out of control, strong CMS pressure, earnings expectations revised downward.

• Historical Correspondences: August 2025 (≈12.7x when Buffett bought the dip), early 2026 ≈14–16x.

• Meaning: Clearly mispriced, high margin of safety, suitable for left-side positioning.

• Trigger Conditions: MCR \>88%, consecutive EPS declines, regulatory risks unresolved.

II. Fair Value Range (Value Center)

17–22x (Dynamic PE)

• This has been UNH's normal valuation center over the past 10 years (average ≈20–22x).

• Corresponds to: Stable MCR 83–85%, EPS annual growth 8–12%, neutral CMS policy.

• Meaning: Normal company operations, fair valuation, suitable for holding.

• 2021–2023 Steady State: PE ≈19–22x.

III. Overvalued Range (Growth Premium/Bubble Zone)

≥23x (Dynamic PE)

• Characteristics: Market optimism, MCR <83%, accelerating EPS growth, favorable policy.

• Historical High: November 2024 (≈25x at $608).

• Meaning: Valuation pricing in future growth, suitable for reducing position/waiting.

• Only sustainable when earnings exceed expectations and valuation multiples rise simultaneously.  
IV. Quick Summary (by Dynamic PE)

• ✅ Undervalued: ≤16x (Bargain hunting)

• ⚖️ Fair: 17–22x (Fair price)

• ❌ Overvalued: ≥23x (A bit expensive)

V. Current Position (2026-03-28)

• Stock Price: $259

• 2026 Expected EPS: $17.7–17.8

• Dynamic PE ≈14.6x → Clearly in the undervalued range.

## Calculate Corresponding Price Targets Based on These Three Ranges

Current consensus 2026 EPS ≈ $17.75  
Applying this EPS to different PEs gives the corresponding stock price.

I. Corresponding Prices for Each Range (Very Intuitive)

1) Undervalued Range: PE ≤ 16

• PE 14x → $248.5

• PE 15x → $266.25

• PE 16x → $284.00  
Current price ~$259 is in the severely undervalued zone.  
2) Fair Value Range: PE 17～22

• PE 17x → $301.75

• PE 18x → $319.50

• PE 19x → $337.25

• PE 20x → $355.00

• PE 21x → $372.75

• PE 22x → $390.50  
To return to fair valuation, the stock price needs to reach at least $300～$390.  
3) Overvalued Range: PE ≥ 23

• PE 23x → $408.25

• PE 24x → $426.00

• PE 25x → $443.75  
Anything above that is bubble/sentiment premium.  
II. Regarding Your Previous Concern About $600

It's impossible to reach $600 based on the 2026 EPS of $17.75:

• $600 ÷ 17.75 ≈ 33.8x PE  
Historically, it has almost never been that high, which would be an extreme bubble.

To truly return to $600, it would require:

• Future EPS rising to $24～$25

• Simultaneously, PE returning to 24～25x  
III. One-Sentence Summary (Easy to Remember)

• ≤ $284: Clearly undervalued, safe zone.

• $300～$390: Fair value range.

• ≥ $408: Overvalued, expensive zone.

### 相关股票

- [Unitedhealth (UNH.US)](https://longbridge.com/zh-CN/quote/UNH.US.md)